ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

Children’s Oncology Group Study Shows Improved Care For Childhood Brain Tumors

October 31, 2008

Michael Grever To Head DTP; Chabner’s Deputy Is Kaufman; Radiation Program To Be Split

April 5, 1991

Ethics Advisory Board to Consider Compensation Issue

September 7, 1979

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

November 30, 2012

FDA Encourages Study Of Gender Differences

August 6, 1993